Allocated and Lost: Tracing the Federal Research Dollars That Never Reach a Laboratory

Every year, the United States Congress approves hundreds of pages of appropriations legislation. Buried within those pages are line items allocating billions of dollars to federal research agencies — the National Institutes of Health, the National Science Foundation, the Department of Energy's Office of Science, and dozens of others. The dollar figures are real. The accountability for where they go is not.

A months-long review of federal budget documents, agency financial disclosures, and congressional testimony conducted by the Full Disclosure Project, combined with interviews with former federal budget analysts, reveals a systematic pattern: research appropriations are routinely redistributed through mechanisms that are technically legal, minimally disclosed, and practically impossible for the public — or even most members of Congress — to trace.

The Architecture of Disappearance

The process begins at the appropriations stage. Research funding is often allocated in broad categorical terms rather than project-specific line items. A provision authorizing "biomedical research initiatives" or "energy technology development" may carry a billion-dollar figure with no statutory requirement that the agency report how that figure is subdivided once it clears the Treasury.

From there, several redistribution mechanisms come into play. Inter-agency transfer authority — granted routinely in appropriations bills through language that rarely attracts floor debate — allows agencies to move funds to other federal entities for "related purposes." What qualifies as related is largely determined by the receiving agency. The transferred funds then appear in a different agency's financial statements, often under a program category that bears no obvious connection to the original appropriation.

Contingency funds present a parallel problem. Many research agency budgets include reserve accounts designated for "unforeseen programmatic needs." These accounts are funded by Congress but managed entirely at agency discretion. They are not subject to the same reporting requirements as primary program accounts, and their use is typically disclosed only in aggregate annual financial summaries — documents that arrive long after the fiscal year has closed and the funds have been spent.

What Former Analysts Say

The individuals who have worked inside this system describe it with a consistency that is difficult to dismiss as coincidence.

"There was a standard playbook," said one former budget analyst who spent more than a decade at a major federal research agency and agreed to speak on background. "If a program was politically inconvenient or the findings were heading somewhere leadership didn't want them to go, you didn't cancel it — cancellation creates a paper trail and attracts attention. You transferred the funds. You reclassified the account. You let the program quietly expire at the end of the fiscal year and didn't re-request it. The money moved, but there was no announcement, no explanation."

A second former official, who worked on appropriations oversight for a congressional committee, described the challenge from the legislative side. "We would appropriate funds for a specific research purpose and then try to track them through agency financial reports. In a significant number of cases, we simply couldn't. The funds had moved through two or three inter-agency transfers, had been reclassified under different program codes, and were now sitting in an account that the agency described as a general operations reserve. You couldn't prove the money was misused. You also couldn't prove it was used for anything it was supposed to be used for."

Vague Line Items as Institutional Cover

The problem is compounded by the deliberate vagueness of many appropriations line items. When Congress writes funding authority in broad terms, it is often doing so at the explicit request of the agencies themselves, which argue that flexibility is necessary to respond to changing research priorities. That argument is not without merit in principle. In practice, it creates an accountability vacuum.

An analysis of NIH and NSF budget justification documents submitted to Congress over a recent five-year period found that a substantial proportion of discretionary research funds were allocated under program descriptions broad enough to accommodate nearly any scientific activity — or none. Agencies are required to submit spending reports, but the level of granularity in those reports is largely self-determined, and there is no independent body with the authority and resources to audit whether reported expenditures correspond to actual research outputs.

The Government Accountability Office has flagged this problem in multiple reports over the past two decades. The recommendations in those reports have been acknowledged by agencies, incorporated into internal policy documents, and largely ignored in practice.

Science Funding as a Political Instrument

What emerges from this accounting is not merely a story about bureaucratic inefficiency. It is a story about power. The ability to redirect research funding without public disclosure is also the ability to determine which scientific questions get answered and which do not. When funds allocated for climate research migrate into a general operations account, that is not a neutral administrative decision. When appropriations for pandemic preparedness are transferred to a contingency reserve that is never drawn down, the consequences are measurable in human terms.

The researchers who were supposed to receive that funding — and who may have structured their careers around the expectation of federal support — are not notified when the funds move. The scientific community learns about these redirections, if it learns about them at all, through the absence of expected grant announcements or the quiet closure of research programs.

The Case for Granular Accountability

The solution is not complicated to describe, even if it is politically difficult to achieve. Research appropriations should carry line-item specificity sufficient to enable independent tracking. Inter-agency transfers of research funds should require advance notice to the relevant congressional appropriations subcommittees and public disclosure within 30 days. Contingency accounts within research agencies should be subject to the same reporting requirements as primary program accounts.

None of these proposals would prevent agencies from exercising legitimate programmatic flexibility. They would simply ensure that when flexibility is exercised, the public knows about it.

Until that standard is met, the billions that Congress appropriates for American science will continue to flow into a system that is designed, at its operational core, to make them untraceable.